Introduction
Antithyroid drugs derived from thionamides, includ-
The microbiology of such infectious complications has not been systematically reviewed previously. In ing methimazole and carbimazole, have been widely this report, we describe 13 cases of antithyroid used to treat patients with hyperthyroidism since drug-induced agranulocytosis complicated by life1940s. They are convenient, effective and cheap.
threatening sepsis, and review the reported cases in Side-effects of these drugs are few, and include skin the English literature. Our findings emphasize the rashes, urticaria, arthralgia and fever. The symptoms importance of Gram-negative bacilli, especially are usually mild and transient.1 Leukopenia, which Pseudomonas aeruginosa, as one of several aetiolomay occur in untreated patients with thyrotoxicosis2 gies of these infectious complications. and in 1-5% of patients treated with antithyroid drugs,1,3 is usually benign and does not increase the risk of agranulocytosis and infection. Agranulocytosis (absolute neutrophil count, ANC <500×106/l) is Methods rare, and may develop in 0.2-0.5% of patients taking antithyroid drugs. 4 It may occur suddenly and explosBetween January 1987 and December 1997, all ively,5 and may be complicated by severe infections cases of hyperthyroidism at National Taiwan University Hospital were retrospectively reviewed in otherwise immunocompetent patients.
using the International Classification of Diseases 9th carbimazole or methimazole. Eleven patients received methimazole 15-30 mg per day for 16-122 Revision, Clinical Modification 4th edition (ICD-9-CM).6 Medical records of patients with thyrotoxdays (median 42 days). The other two patients (5 and 9) received carbimazole 30 mg per day for 21 icosis, with/without goitre (disease code number 242), combined with leukopenia/agranulocytosis and 61 days, respectively. The initial leukocyte count at the presentation of (disease code number 288.0), were reviewed. Patients who developed agranulocytosis due to antisepsis ranged from 240 to 1960×106/l (median 800×106/l) and ANC ranged from 0 to 236×106/l thyroid drugs (thionamides or propylthiouracil) were identified and formed the basis of this study. Patients (median 0/l). The presenting symptoms of the infectious complications were fever (92%), sore throat with leukopenia attributable to other drugs or medical illnesses were excluded.
(85%), chills (38%), watery diarrhoea (15%), nausea (15%), vomiting (15%), oral ulcers (15%), productive A standardized case record form was used to record demographic data, thyroid diseases, concomcough (15%), dyspnoea (8%), headache (8%) and dysuria (8%). Initial clinical diagnoses based on the itant medical illness, dosage and duration of the offending antithyroid drugs. Clinical presentation and symptomatology were acute pharyngitis (46%), acute tonsillitis (38%), pneumonia (15%) and urinary tract sites of infection, microbiological results, treatment (including use of granulocyte colony-stimulating infection (8%). Eight of 13 patients had their causative organisms factor, G-CSF), duration of recovery of leukocyte count after discontinuing medication, and final outidentified from blood (six patients), pus from tonsillar abscess (1) or pus of leg ulcer (1). Three of our six come of patients with agranulocytosis induced by antithyroid drugs were also recorded on the form. bacteraemia patients had positive cultures from retropharyngeal abscess (1), peritonsillar abscess (1) or Agranulocytosis was defined as an blood absolute neutrophil count (ANC) <500×106/l. Sepsis in urine (1) Pseudomonas aeruginosa was the most common pathogen isolated (four patients), followed these patients was defined as clinical evidence of infection plus a systemic inflammatory response to by Escherichia coli (1), Klebsiella pneumoniae (1), methicillin-sensitive Staphylococcus aureus (1), and infection. This systemic response was manifested by at least two of the following three conditions: (i) oral Capnocytophaga species (1). Blood cultures were positive in six patients, three of which grew P. temperature of >38°C or <36°C; (ii) respiratory rate of >20 breaths/min or PaCO 2 of <32 torr; aeruginosa. All patients received intensive care, empirical (iii) heart rate of >90 beats/min. 7 Statistical analysis was performed using SPSS stattherapy with antipseudomonal antibiotics and surgical drainage of pus. G-CSF 5 mg/kg of body weight istical software (Version 6.1.3). The non-parametric Mann-Whitney U test was used for comparison of was given to 6/13 patients. All surviving patients had recovery of ANC after discontinuation of antithyroid the duration of leukocyte count recovery between patients treated with G-CSF and those without G-CSF.
drugs. The time to recovery was 4-12 days (median 9 days) in patients treated with G-CSF, and 5-10 A p value of 0.05 or less was considered significant.
The literature was reviewed by searching days (median 7 days) in patients treated without G-CSF ( p=0.84). Two patients died, having MEDLINE using the index terms of neutropenia, agranulocytosis and antithyroid drugs (including prodeveloped uncontrolled infection, thyroid storm and multiple organ failure. pylthiouracil and thionamides). References or bibliographies cited in each article concerning antithyroid In a search of MEDLINE for the period from 1965 to December 1997, we identified nine other patients drug-induced agranulocytosis were also reviewed.
with agranulocytosis induced by antithyroid drugs who developed community-acquired sepsis with positive microbiological results ( Table 2) .
8-14 The clinical
Results presentations were fever (seven patients), sore throat (4), and diarrhoea (2), while clinical diagnoses were There were a total of 5653 patients with hyperthyroidism who were treated with antithyroid drugs (thionacute tonsillopharyngitis (3), colitis (2) and pneumonia (1). K. pneumoniae (3) and P. aeruginosa (2), amides and propylthiouracil) at National Taiwan University Hospital between January 1987 and were the most common causes of bacteraemia, followed by Enterobacter aerogenes (1), E. coli (1), December 1997. Thirteen (0.23%) of them developed agranulocytosis induced by antithyroid drugs, and S. aureus (1), and group G Streptococcus (1). The associated complications described in these patients all 13 had obvious symptoms and signs consistent with sepsis (Table 1 ). There were three males and 10 were septic shock (2), thyroid storm (2), colon perforation (1), retroperitoneal abscess (1), drugfemales, with a median age of 39 years (range 17-78 years). Three had Graves' disease and 10 had toxic induced hepatitis (1), disseminated intravascular coagulation (1), pneumonia (1) and multiple-organ multinodular goitres. All 13 received thionamides- ARDS, acute respiratory distress syndrome; CHF, congestive heart failure; CMZ, carbimazole; DIC, disseminated intravascular coagulation; DM, diabetes mellitus; GAD, Graves' disease; G-CSF, granulocyte colony-stimulating factor; MMZ, methimazole; TMG, toxic multinodular goitre; UTI, urinary tract infection. dysfunction syndrome (1). All patients but one suroral cavity, and the most common clinical diagnoses were acute pharyngitis or tonsillitis. Symptoms may vived. The fatal case (case 3) was a 48-year-old female, who received methimazole for 49 days mimic viral infections, and potentially life-threatening pyogenic infections are not usually diagnosed inibefore agranulocytosis was detected. She suffered from fever, chills and bloody diarrhoea on admission.
tially. Therefore, timely and appropriate therapy may not be administered. In three of our patients, severe Blood cultures grew P. aeruginosa and K. pneumoniae. The ANC was 11×106/l and returned pyogenic infectious complications developed, such as peritonsillar and retropharyngeal abscesses, and to normal 10 days after discontinuation of methimazole. A colon resection was done because of persistairway obstruction or pneumonia, with resultant acute respiratory distress syndrome. ent bloody diarrhoea and the surgical findings showed retroperitoneal abscess, haematoma and
The microbiology of infectious complications of antithyroid drug-induced agranulocytosis is rarely rectal perforation. The patient died of persistent, massive, intractable bleeding.
described in the literature. In our study and review of previous reports, we found that the majority of causative micro-organisms were Gram-negative bacilli.8-14 In our study and others combined, P.
Discussion aeruginosa was the most common isolate (7/23), followed by K. pneumoniae (5/23), E. coli (3/23) and To our knowledge, this is the first report systematically to review infectious complications and their S. aureus (3/23) in cultures obtained from all infection sites. microbiology related to antithyroid drug-induced agranulocytosis. We found that the incidence of life-P. aeruginosa was the leading cause of communityacquired sepsis in patients with antithyroid drugthreatening infection related to antithyroid-druginduced agranulocytosis was 0.23%. P. aeruginosa induced agranulocytosis. The organism causes bacteraemia or other invasive infections primarily was the most common pathogen isolated in these infections. Leukopenia in patients with hyperthyroidin a nosocomial setting or in immunocompromised patients, with neutropenia as one of the most importism may be caused by thyrotoxicosis itself or related to antithyroid drugs.2 In patients taking anti-thyroid ant predisposing conditions.22 Infection with P. aeruginosa usually begins with colonization, followed by drugs, the absolute neutrophil count rarely falls below 2000×106/l, which is not associated with a break in host defenses with local invasion, and culminates in dissemination and systemic disease, increased risk of infection and does not necessitate drug withdrawal.3,15 However, in 0.2%-0.5% of which is associated with high mortality.23,24
In our patients, all episodes of sepsis were compatients treated with antithyroid drugs, agranulocytosis may develop and may be associated with a munity-acquired; patients had no previous chemotherapy or antibiotic treatment. The reason for the high risk of life-threatening infections.4,16 In our study, the incidence of antithyroid-drug-induced development of sepsis might be agranulocytosis and mucosal ulceration. In previous studies,25-27 agranulocytosis (0.23%) was comparable to that of previous reports.
there appears to be a clear relationship between Pseudomonas colonization of the respiratory tract Agranulocytosis may occur in any age group, without gender difference, and usually occurs within and bacterial adherence to buccal epithelial cells. Most of the patients with antithyroid drug-induced 2 months of initiation of antithyroid drug therapy, with the elderly being most vulnerable.5,17 All but agranulocytosis in this review suffered pharyngitis and tonsillitis. With the predominant presentation of one of our patients developed agranulocytosis within a median of 61 days while taking appropriate therapharyngitis and ulceration of the oral mucosa, the oropharynx might have provided a largely unopposed peutic dosages of thionamides. Recent studies have shown that the mechanism of antithyroid druginitial break in host defenses to tissue invasion during the period of neutropenia.28 induced agranulocytosis is an immunological phenomenon, rather than a direct toxic effect of antithyrBecause the occurrence of antithyroid-druginduced agranulocytosis is sudden and explosive, it oid drugs.18,19 Lower dosages of antithyroid drug do not decrease the incidence of agranulocytosis, and is potentially fatal. It is reasonable to obtain a baseline leukocyte count before initiation of antithyrit may develop in the second course of therapy even if the first course was uneventful.20 oid drug therapy.3 When therapy is begun, the patient should be instructed to notify the physician The clinical evidence of infectious complications associated with antithyroid-drug-induced agranuloimmediately if fever or sore throat develops2,29 and the leukocyte count must be checked. cytosis is usually symptomatology in the oropharyngeal region. 8 
